| 000 | 01777 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250518082046.0 | ||
| 264 | 0 | _c20200928 | |
| 008 | 202009s 0 0 eng d | ||
| 022 | _a1098-5514 | ||
| 024 | 7 |
_a10.1128/JVI.01912-19 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMelody, Kevin | |
| 245 | 0 | 0 |
_aLong-Acting Rilpivirine (RPV) Preexposure Prophylaxis Does Not Inhibit Vaginal Transmission of RPV-Resistant HIV-1 or Select for High-Frequency Drug Resistance in Humanized Mice. _h[electronic resource] |
| 260 |
_bJournal of virology _c03 2020 |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAnti-HIV Agents _xpharmacology |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 |
_aDrug Resistance, Viral _xdrug effects |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHIV Infections _xdrug therapy |
| 650 | 0 | 4 |
_aHIV-1 _xdrug effects |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMutation |
| 650 | 0 | 4 |
_aPre-Exposure Prophylaxis _xmethods |
| 650 | 0 | 4 |
_aReverse Transcriptase Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aRilpivirine _xpharmacology |
| 650 | 0 | 4 |
_aVagina _xvirology |
| 650 | 0 | 4 |
_aVirus Replication _xdrug effects |
| 650 | 0 | 4 |
_agag Gene Products, Human Immunodeficiency Virus _xgenetics |
| 700 | 1 | _aRoy, Chandra N | |
| 700 | 1 | _aKline, Christopher | |
| 700 | 1 | _aCottrell, Mackenzie L | |
| 700 | 1 | _aEvans, Dwayne | |
| 700 | 1 | _aShutt, Kathleen | |
| 700 | 1 | _aPennings, Pleuni S | |
| 700 | 1 | _aKeele, Brandon F | |
| 700 | 1 | _aBility, Moses | |
| 700 | 1 | _aKashuba, Angela D M | |
| 700 | 1 | _aAmbrose, Zandrea | |
| 773 | 0 |
_tJournal of virology _gvol. 94 _gno. 8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1128/JVI.01912-19 _zAvailable from publisher's website |
| 999 |
_c30549064 _d30549064 |
||